A subpopulation of pericytes expressing the Glast-CreERT2 transgene (Type A pericytes) has recently been identified as the main source of stromal scar tissue that forms after SCI. Identification of molecules associated with pericyte-derived scarring may offer new therapeutic targets to facilitate axon regeneration following central nervous system (CNS) injury. We conducted genome-wide RNA sequencing of (i) uninjured spinal cord segments and (ii) lesion sites presenting full or attenuated pericyte-derived scarring 14 days after SCI. SOURCE: Joakim Lundeberg KTH-Science for Life Laboratory

Pluto Bioinformatics

GSE93976: In vivo analysis of injury sites presenting full or attenuated pericyte-derived scarring after spinal cord injury (SCI)